Report Highlights
The global market for OTC medicines and dietary supplements reached $128.8 billion in 2012. This market is expected to reach to $142.7 billion in 2013 and $189.7 billion in 2018, with a compound annual growth rate (CAGR) of 5.9%.
Report Includes
- An overview of the global market for OTC drugs and dietary supplements.
- Analyses of global market trends, with data from 2012 and 2013, and projections of CAGRs through 2018.
- Information about how pharmacies affect the OTC drug market
- Updates on the latest merger and acquistion activity
- Company profiles of major players in the market
Report Scope
The report covers developed and emerging markets in order to help readers understand:
- The current state of the OTC medicines and dietary supplements market and the key markets for its future development.
- New regulations that will influence the development of the OTC medicines and dietary supplements market.
- Market drivers of and threats to the OTC medicines and dietary supplements industry.
- Major regional trends in the global OTC medicines and dietary supplements market.
- The competitive thrust of the market.
Analyst Credentials
Anand Gijare has over 20 years of experience in consumer healthcare medicines and products. He has helped companies conduct research on product developments, competitive market analysis, consumer behavior analysis and supply chain dynamics in consumer healthcare. His key focus has been studying marketing strategies in consumer healthcare, and he provides precise consultation on the gaps between market's hidden desires and available opportunities. He is proficient in identifying opportunities for new products in consumer healthcare-based on integration of advanced technologies and smart materials.
Report Highlights
-
In 2005, the herbal supplements market for products covered in this report was only 0.47% of the prescription market for drugs to treat these conditions. It is unlikely that the herbal supplements market will ever represent more than a very small percentage of the prescription drug market. For those categories where OTC products exist-treatments for nausea, heartburn and insomnia-OTC revenues represented 4.3%, 14.2% and 7.2% of prescription drug markets for these categories, respectively, in 2005.
-
The global market for herbal supplements covered in this report was $5.5 billion in 2005 and $5.6 billion by the end of 2006. Growing at an average annual growth rate (AAGR) of 1.7%, this market sector will cross just over $6.1 billion by 2011.
-
The global market for prescription drugs was worth more than $114 billion in 2005 and almost $120 billion in 2006. At an AAGR of 4.6%, this market will grow to reach almost $150 billion by 2011.
Related Reports
Global Markets and Manufacturing Technologies for Protein Drugs
The global protein therapeutics market reached $138.3 billion in 2012. This market is expected to decline to $136.7 billion in 2013 and then increase to nearly $179.1 billion in 2018, a compound annual growth rate (CAGR) of 5.6% over the five-year period from 2013 to 2018.
Global Markets for Orphan Drugs
The global market for orphan drugs reached nearly $86.1 billion in 2012. The market is expected to reach $112.1 billion in 2017 for a compound annual growth rate (CAGR) of 5.4%.
Recent Reports
Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions
The global market for cancer therapeutics emphasizing recurrent and metastatic divisions is expected to grow from $116.1 billion in 2024 to reach $168.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.7% from 2024 to 2029.
Epigenetics: Technologies and Global Markets
The global market for epigenetics research tools and reagents, IVDs and therapeutics is expected to grow from $4.8 billion in 2024 to $8.5 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.8% from 2024 through 2029.
High-Throughput Screening: Technologies and Global Markets
The global market for high-throughput screening (HTS) is expected to grow from $23.8 billion in 2024 to $39.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.5% from 2024 through 2029.
Neurology Market: A BCC Research Overview
The global market for neurology is estimated to increase from $67.3 billion in 2024 to reach $94.8 billion by 2029, at a compound annual growth rate (CAGR) of 7.1% from 2024 through 2029.
2023 Pharmaceuticals Research Review
This Pharmaceutical Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since the inception of BCC Research in 1971.
Top Trending Reports
Carbon Capture, Utilization & Storage Technologies
The global market for carbon capture, utilization and storage (CCUS) technologies is expected to grow from $3.4 billion in 2024 and is projected to reach $9.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.1% during the forecast period of 2024 to 2029.
2024 Semiconductor Manufacturing Research Review
This 2024 Research Review of the Semiconductor Manufacturing provides a sampling of the type of quantitative market information, analysis, and guidance that BCC Research has been developing since its inception in 1971 to help its customers make informed business decisions.
Generative AI: Global Markets
The global market for generative AI was valued at $15.4 billion in 2023. It is projected to grow from $20.8 billion in 2024 to $94.4 billion by 2029, at a compound annual growth rate (CAGR) of 35.3% from 2024 through 2029.
Global Diabetic Care Devices Market
The global market for diabetes monitoring devices is expected to grow from $16.6 billion in 2024 to $26.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.1% from 2024 through 2029.
2024 Medical Devices Research Review
The medical device industry is a multi-billion-dollar industry whose outlook is supposed to rise in the coming years These devices treat and diagnose a multitude of patient conditions and work much better than drugs.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More